Back to Search
THOMAS LYNCH, MD
MD
General Practice Physician
NPI: 1528046364Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.
PMID 19633475·J Thorac Oncol·2009
3-trial
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
PMID 17708140·Am Fam Physician·2007
6-review
Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.
PMID 17671145·Clin Cancer Res·2007
7-preclinical
Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach.
PMID 17096462·Int J Geriatr Psychiatry·2007
2-rct
Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
PMID 16857812·Clin Cancer Res·2006
7-preclinical
Medication costs as a primary cause of nonadherence in the elderly.
PMID 16524358·Consult Pharm·2006
8-other
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
PMID 16000599·Clin Cancer Res·2005
8-other
BC 2003 wildland urban interface fires: managing an integrated health system during a regional emergency.
PMID 15581136·Health Law Can·2004
8-other
Novel agents in the treatment of lung cancer: conference summary statement.
PMID 15217958·Clin Cancer Res·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1900 16TH ST
GREELEY, CO 80631 - Phone
- (970) 350-2471
Quick Facts
- NPI
- 1528046364
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile